EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-PLA2R autoantibodies induce complement activation via IgG subclass–dependent epitope pairings in membranous nephropathy

Tsai-Yi Wu, Kun-Hua Tu, Larissa Seifert, Kung-Wei Lin, Han-Po Shih, Yu-Fang Lo, Jhan-Jie Peng, Gunther Zahner, Oliver Kretz, You-Ning Lin, Chen-Xuan Kang, Jing-Ya Ding und 8 weitere

Journal of Clinical Investigation · 02.11.2026 · 136 (21)

DOI: 10.1172/jci191995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 08.09.2026. Verfasst von Tsai-Yi Wu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Immunology and Infectious Disease, Institute of Immunology and Translational Medicine, College of Medicine, Chang Gung University…. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Receptors, Phospholipase A2, Autoantibodies, Complement Activation. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Chang Gung Memorial Hospital, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Membranous nephropathy (MN) is an autoimmune kidney disease and a major cause of nephrotic syndrome in adults. Although autoantibodies against phospholipase A2 receptor 1 (PLA2R) and complement activation are central to disease pathogenesis, the mechanisms by which anti-PLA2R antibodies activate complement at the podocyte surface remain incompletely defined. Here, we cloned 14 patient-derived anti-PLA2R mAbs and found that they predominantly recognized the N-terminal cysteine-rich (CysR) and C-type lectin domain 1 (CTLD1) regions of PLA2R. Individual anti-PLA2R mAbs induced little or no complement-dependent cytotoxicity (CDC) of PLA2R-expressing podocytes in vitro. In contrast, paired mAbs targeting distinct epitopes, particularly CysR and CTLD1, markedly enhanced CDC. This effect was strongest for IgG1 and IgG3 antibodies, whereas IgG4 alone did not activate complement but modulated CDC in combination with IgG1. Purified IgG from patients with PLA2R-associated MN similarly induced CDC, which was augmented by addition of anti–PLA2R IgG1 and reduced by anti–PLA2R IgG4 or Fab fragments targeting CysR or CTLD1. In human PLA2R–expressing mice, paired anti-PLA2R antibodies increased glomerular complement deposition and induced albuminuria. These findings identify epitope pairing as a key determinant of complement activation in PLA2R-associated MN and support epitope-specific targeting strategies as a promising avenue for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousReceptors, Phospholipase A2AutoantibodiesComplement ActivationImmunoglobulin GEpitopesHumansAnimalsMicePodocytesFemaleMice, Transgenic

Stichwörter der Autor:innen

Autoimmune diseasesAutoimmunityImmunologyNephrology

Substanzen

Receptors, Phospholipase A2AutoantibodiesImmunoglobulin GEpitopesPLA2R1 protein, human

Autor:innen und Institutionen

  • Laboratory of Human Immunology and Infectious Disease, Institute of Immunology and Translational Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • III. Department of Medicine, and.
  • Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Kidney Research Center, Department of Nephrology, Chanα-g Gung Memorial Hospital, Taoyuan, Taiwan.
  • Institute of Microbiology and Immunology, School of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Förderung

  • National Science and Technology Council
  • Chang Gung Memorial Hospital
  • German Research Foundation
  • Else Kröner Fresenius Foundation
  • European Research Council

Zitieren

APA

Wu, T. Y., Tu, K. H., Seifert, L., Lin, K. W., Shih, H. P., Lo, Y. F., Peng, J. J., Zahner, G., Kretz, O., Lin, Y. N., Kang, C. X., Ding, J. Y., Tu, Y. R., Ma, L. Y., Chuang, Y. T., Lo, C. C., Tsai, Y. H., Yang, C. W., Tomas, N. M., & Ku, C. L. (2026). Anti-PLA2R autoantibodies induce complement activation via IgG subclass–dependent epitope pairings in membranous nephropathy. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci191995

Vancouver

Wu TY, Tu KH, Seifert L, Lin KW, Shih HP, Lo YF, et al. Anti-PLA2R autoantibodies induce complement activation via IgG subclass–dependent epitope pairings in membranous nephropathy. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci191995

BibTeX
@article{Wu2026,
  author = {Wu, Tsai-Yi and Tu, Kun-Hua and Seifert, Larissa and Lin, Kung-Wei and Shih, Han-Po and Lo, Yu-Fang and Peng, Jhan-Jie and Zahner, Gunther and Kretz, Oliver and Lin, You-Ning and Kang, Chen-Xuan and Ding, Jing-Ya and Tu, Yi-Ran and Ma, Li-Yi and Chuang, Ya-Ting and Lo, Chia-Chi and Tsai, Yu-Huan and Yang, Chih-Wei and Tomas, Nicola M and Ku, Cheng-Lung},
  title = {Anti-PLA2R autoantibodies induce complement activation via IgG subclass–dependent epitope pairings in membranous nephropathy},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {21},
  doi = {10.1172/jci191995}
}
Kostenlos starten →